P3.03-07 Co-Occurring Genomic Alterations in EGFR Altered Chinese Lung Adenocarcinoma Patients

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1684
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status

PLoS ONE
Multidisciplinary
2013English

MA24.02 Genomic Alterations in Lung Adenocarcinoma Precursor Lesions

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MET-EGFR Dimerization in Lung Adenocarcinoma Is Dependent on EGFR Mtations and Altered by MET Kinase Inhibition

PLoS ONE
Multidisciplinary
2017English

The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation

Green Medical Journal
2020English

EGFR Inhibitors in Treatment of Lung Adenocarcinoma

Research in Oncology
2014English

Correlation Between Serum CEA Levels and EGFR Mutations in Chinese Nonsmokers With Lung Adenocarcinoma

Acta Pharmacologica Sinica
MedicinePharmacology
2014English

EGFR Genomic Alterations in Cancer: Prognostic and Predictive Values

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2009English

P2.01-09 Targetable Genomic Alterations in KRAS Mutant Lung Adenocarcinoma by Targeted Next Generation Sequencing

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy